Non-small Cell Lung Cancers: Clinical Trials

3 trials for Non-small Cell Lung Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow Non-small Cell Lung Cancers: new trials by email Literature Review of Non-small Cell Lung Cancers trials Research Report on Non-small Cell Lung Cancers

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
Adagrasib, Olaparib - Advanced Solid Tumor, Non-small Cell Lung Cancers
Phase 1TerminatedM.D. Anderson Cancer Center12024-01-302026-04-09
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
PRT3789, Docetaxel - Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1CompletedPrelude Therapeutics Incorporated1352023-05-022025-10-16
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PRT3645 - Breast Cancer, Glioblastoma
Phase 1CompletedPrelude Therapeutics Incorporated222022-12-272024-07-01

Narrower conditions

Breast Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Glioblastoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasm Metastasis (1)  ·  Sarcoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Neoplasms (2)  ·  Adenoma (1)  ·  Astrocytoma (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)

Interventions

Docetaxel (1)  ·  adagrasib (1)  ·  olaparib (1)

Sponsors

Prelude Therapeutics Incorporated (2)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (3)  ·  Singapore (2)  ·  France (1)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

Timothy Yap, MD (1)